Medication info

Tamsetone 40 weeks (Triamcinolone Acetonide)

Prescription medicationInjectionsInjection
Ingredient · strength
Triamcinolone Acetonide›40mg / 1 vial
Manufacturer / importer
Hanol Biopharma Co., Ltd.
Appearance
A white, translucent suspension in a vial
Packaging
1mL/vial x 50 vials
Approval status
Active

MFDS item code 198200139 · Notified 1982.01.05 · Insurance code 655601771

Summary

Main use
Treatment of joint, rheumatic, and collagen diseases; endocrine, skin, and allergic diseases; and eye, intestinal, and blood disorders
Who receives it
Adults · Children
Adult administration
1. Intra-articular, intrabursal, and intrasheath injection Adults: 2 ~ 40 mg of triamcinolone acetonide per dose; in principle, inject at intervals of 2 weeks or longer, adjusting the dose as appropriate. 2. Intramuscular injection Adults: The usual initial dose of this drug is 40 mg, injected deep into the gluteal muscle. Adjust within the range of 20 ~ 80 mg at intervals of 1 ~ 2 weeks according to the patient's therapeutic response. 3. Local intradermal injection Adults: The initial dose of this drug varies according to the condition. However, because administration of large doses may cause local tissue atrophy, inject 0.2 ~ 1 mg per dose, up to 10 mg, once weekly.
Child administration
2. Intramuscular injection Children aged 12 years and older: The usual initial dose of this drug is 40 mg, injected deep into the gluteal muscle. Adjust within the range of 20 ~ 80 mg at intervals of 1 ~ 2 weeks according to the patient's therapeutic response. Children aged 6 ~ 12 years: An initial dose of 40 mg is appropriate; adjust according to age, body weight, and symptoms. Not recommended for children 6 years of age or younger.

Ingredients

Manufacturer
Hanol Biopharma Co., Ltd.

Efficacy & effects

Treatment of joint, rheumatic, and collagen diseases; endocrine, skin, and allergic diseases; and eye, intestinal, and blood disorders

  • Synovitis in osteoarthritis
  • rheumatoid-like arthritis
  • acute bursitis
  • subacute bursitis
  • acute gouty arthritis
  • epicondylitis
  • acute tendinitis
  • nonspecific tendinitis
  • post-traumatic osteoarthritis
  • primary adrenal cortical insufficiency
  • secondary adrenal cortical insufficiency
  • psoriatic arthritis
View approved original text

This medication is effectively used for various conditions. It helps in the short-term treatment of inflammatory diseases of the joints and bursae, such as synovitis in osteoarthritis, rheumatoid-like arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, tendinitis, and post-traumatic osteoarthritis through intra-articular injections. Additionally, it is used by intramuscular injection for various rheumatic diseases, collagen diseases, dermatological diseases, allergic diseases, ophthalmic diseases, gastrointestinal diseases, and hematological diseases, including endocrine disorders such as adrenal cortical insufficiency, especially when oral therapy is difficult. It can also be used for intradermal injections in the treatment of lichen planus (malignant), early keloids, and alopecia areata. Therefore, it is a drug effective for treating various conditions such as arthritis, dermatitis, allergies, ophthalmic, and hematological diseases.

How it is given

Adult administration

1. Intra-articular, intrabursal, and intrasheath injection Adults: 2 ~ 40 mg of triamcinolone acetonide per dose; in principle, inject at intervals of 2 weeks or longer, adjusting the dose as appropriate. 2. Intramuscular injection Adults: The usual initial dose of this drug is 40 mg, injected deep into the gluteal muscle. Adjust within the range of 20 ~ 80 mg at intervals of 1 ~ 2 weeks according to the patient's therapeutic response. 3. Local intradermal injection Adults: The initial dose of this drug varies according to the condition. However, because administration of large doses may cause local tissue atrophy, inject 0.2 ~ 1 mg per dose, up to 10 mg, once weekly.

Child administration

2. Intramuscular injection Children aged 12 years and older: The usual initial dose of this drug is 40 mg, injected deep into the gluteal muscle. Adjust within the range of 20 ~ 80 mg at intervals of 1 ~ 2 weeks according to the patient's therapeutic response. Children aged 6 ~ 12 years: An initial dose of 40 mg is appropriate; adjust according to age, body weight, and symptoms. Not recommended for children 6 years of age or younger.

Precautions

This medication is in a suspension form and should not be used for intravenous injection. Injecting epidurally or intrathecally can result in serious side effects, so these methods of administration should be avoided. Patients who are hypersensitive to this medication or have previously experienced allergic reactions should not use it. Patients with infections or systemic fungal infections should not be administered this medication, as it can suppress immunity and exacerbate infections. Patients with thrombocytopenia or purpura, herpes simplex, shingles, or chickenpox should also not use this medication. Care must be taken in using this medication for patients with intra-articular infections or unstable joints as it may exacerbate symptoms. Patients with specific conditions such as tuberculosis, herpetic keratitis, cataracts, glaucoma, hypertension, thrombosis, myocardial infarction, peptic ulcers, schizophrenia, osteoporosis, etc., should use this medication cautiously. Infection patients, those with hypothyroidism, liver cirrhosis, fatty liver, renal failure, heart failure, elderly patients, and diabetic patients also require caution. This medication can lead to various side effects, so it's important to closely monitor fluid retention, hypertension, myalgia, osteoporosis, gastrointestinal issues, skin changes, neuropsychiatric abnormalities, endocrine issues, eye abnormalities, blood disorders, metabolic issues, and respiratory issues during administration. Specifically, intra-articular administration may cause joint instability, intramuscular administration may cause tissue atrophy, and administration in the head and neck area may result in visual disturbances, thus caution is necessary. This medication can promote the replication of the hepatitis B virus in carriers, so liver function tests and virus marker monitoring are needed. In scleroderma patients, renal function and blood pressure should be closely monitored. This medication is recommended to be given at the lowest possible dose for a short duration, paying attention to potential adrenal insufficiency and withdrawal symptoms with long-term use. This medication has many drug interactions, requiring careful control and caution when used with barbiturates, anticonvulsants, rifampicin, NSAIDs, anticoagulants, diuretics, ACE inhibitors, antimalarials, digitalis, cyclosporine, interferon, isoniazid, etc. During pregnancy, it may harm the fetus, and during lactation, it can be transmitted through breast milk affecting the baby, so pregnant and nursing women should use it cautiously. In children, severe side effects such as growth retardation and increased intracranial pressure can occur, so it should be administered at the minimum dose with caution, and tissue atrophy at the injection site should also be considered. Elderly patients are at a higher risk of side effects such as infection, diabetes, osteoporosis, hypertension, cataracts, and glaucoma, requiring cautious observation during administration. During administration, avoid intravenous injection, spinal canal injection, epidural injection, and intrathecal injection, and when administering intramuscularly, avoid the area where nerves run, and if there is pain or blood return during injection, the injection site should be immediately changed.

Side effects

Water retention, sodium retention, congestive heart failure, potassium loss, ECG changes due to deep vein thrombosis or potassium deficiency, hypertension, edema, myalgia, arthralgia, muscle weakness, fatigue, steroid myopathy, loss of muscle mass, osteoporosis, spinal compression fractures, delayed healing of fractures, avascular necrosis of the ends of the femur and humerus, pathological fractures of the iliac bone, idiopathic fractures, tendon rupture, gastric perforation, peptic ulcer, pancreatitis, diarrhea, nausea, vomiting, abdominal pain, heartburn, abdominal distension, ulcerative esophagitis, thirst, anorexia, increased appetite, dyspepsia, abdominal bloating, intestinal/bladder dysfunction, delayed wound healing, epidermal peeling, petechial hemorrhage, facial erythema, hyperhidrosis, purpura, hirsutism, acneiform rash, lesions similar to erythematous lupus, suppression reactions in skin tests, alopecia, lipodystrophy, convulsions, congestion, increased intracranial pressure with papilledema, dizziness, headache, neuritis or paresthesia, euphoria, insomnia, arachnoiditis, meningitis, incomplete/complete paraplegia and sensory disturbances, spinal infarction, paraplegia, quadriplegia, cortical visual loss, stroke, menstrual disorders, postmenopausal vaginal bleeding, Cushing's syndrome, growth suppression in children, secondary adrenal cortex and pituitary unresponsiveness, decreased glucose tolerance, onset of latent diabetes, increased requirement for insulin or oral hypoglycemic agents, buffalo hump, suppression of adrenocorticotropic hormone secretion, increased intraocular pressure, glaucoma, posterior subcapsular cataract, secondary infections of the eye, retinal disorders, exophthalmos, leukocytosis, thrombosis, hyperglycemia, diabetes, negative nitrogen balance due to protein catabolism, worsening of bronchial asthma, shock, anaphylaxis-like reactions and symptoms, dyspnea, generalized flushing, angioedema, urticaria, joint instability, pain, increased tenderness, worsening of swelling, local tissue atrophy, retinal artery occlusion, blindness, visual disturbances, hepatitis due to hepatitis B virus proliferation, scleroderma renal syndrome, vasculitis, thrombophlebitis, thromboembolism, exacerbation or concealment of infections, syncope

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that blocks light, and the storage temperature should be maintained at room temperature between 1 degree and 30 degrees. Storing it this way can safely maintain the medication's effectiveness.

Appearance and packaging

Appearance

A white, translucent suspension in a vial

Package unit

1mL/vial x 50 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.